Abstract
The behavioral profiles of five clinically used selective serotonin reuptake inhibitors (SSRIs) citalopram, paroxetine, sertraline, fluvoxamine and fluoxetine, have been compared in animal models of antidepressant (mouse forced swim test), anxiolytic (exploration of black and white test box and foot-shock-induced ultrasonic vocalization in the rat) and antiaggressive (isolation-induced aggressive behavior in the mouse) activity. The results are discussed in relation to receptor binding data from the literature. Furthermore, affinities for the σ 1 and σ 2 binding sites are presented. Citalopram reversed the immobility induced by forced swimming with a potency similar to that of imipramine. Paroxetine, fluvoxamine and fluoxetine reversed swim-induced immobility less potently and with a maximum of 40–50% reversal. Citalopram produced a mixed anxiogenic-/anxiolyticlike response in rats tested in the two-compartment black and white box. Paroxetine induced an anxiogenic-like response at low doses and the other SSRIs were without major effects. Citalopram and paroxetine inhibited footshock-induced ultrasonic vocalization with high potencies. The dose-response curve was biphasic for citalopram with a maximum of 64% inhibition. Sertraline and fluvoxamine inhibited the vocalization less potently, and fluoxetine induced a weak inhibitory effect corresponding to a maximum of 32%. Sertraline, fluvoxamine and fluoxetine inhibited isolation-induced aggressive behavior, whereas citalopram and paroxetine were inactive. Both 5-HT1 and 5-HT2 receptors are involved, and there was a functional interaction between 5-HT1A and 5-HT2A or 5-HT2C receptors, as ritanserin potentiated the antiaggressive effect of 1,5-HTP as well as that of 8-OH-DPAT.
Similar content being viewed by others
References
Borsini F (1995) Role of the serotonergic system in the forced swimming test. Neurosci Biobehav Rev 19 [3]: 377–395
Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psycho-pharmacology 94:147–160
Bourin M, Colombel M-C, Malinge M, Bradwejn J (1991) Clonidine as a sensitizing agent in the forced swimming test for revealing antidepressant activity. J Psychiatr Neurosci 16 [4]: 199–203
Castrogiovanni P, Di-Muro A, Maremanni I (1992) Fluoxetine reduces aggressive behavior in depressive outpatients. New Trends Exp Clin Psychiat 8:57
Cervo L, Grignaschi G, Rossi C, Samanin R (1991) Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test. Eur J Pharmacol 196:217–222
Cesana R, Ceci A, Ciprandi C, Borsini F (1993) Mesulergine antagonism towards the fluoxetine anti-immobility effect in the forced swimming test in mice. J Pharm Pharmacol 45:473–475
Cornelius JR, Soloff PH, Perel JM, Ulrich RF (1990) Fluoxetine trial in borderline personality disorder. Psychopharmacol Bull 26:151–154
Debonnel G, de Montigny C (1996) Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders. Life Sci 58:721–734
Devane CL (1995) Comparative safety and tolerability of selective serotonin reuptake inhibitors. Hum Psychopharmacol 10 [suppl 3]: 185–193
De Vry J, Benz U, Schreiber R, Traber J (1993) Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs. Eur J Pharmacol 249:331–339
Doogan DP, Caillard V (1988) Sertraline: a new antidepressant. J Clin Psychiatry 49[8]:46–51
Durcan MJ, Lister RG, Eckardt MJ, Linnoila M (1988) Behavioral interactions of fluoxetine and other 5-hydroxytryptamine uptake inhibitors with ethanol in tests of anxiety, locomotion and exploration. Psychopharmacology 96:528–533
Fava M, Rosenbaum JF, Pava JA, McCarthy KK, Steingard RJ, Bouffides E (1993) Anger attacks in unipolar depression. Part 1: clinical correlates and response to fluoxetine treatment. Am J Psychiatry 150:1158–1163
Fletcher A, Cliffe IA, Dourish CT (1993) Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol Sci 14:441–448
Górka Z, Wojtasik E, Kwiatek H, Maj J (1979) Action of sero-toninmimetics in the behavioral despair test in rats. Commuri Psychopharmacol 3:133–136
Heym J, Koe BK (1988) Pharmacology of sertraline: a review. J Clin Psychiatry 49[8]: 40–45
Hyttel J (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 9[1]: 19–26
Kallioniemi H, Suvälahti E (1993) Citalopram, a specific inhibitor of serotonin re-uptake in treatment of psychotic and borderline patients. Nord J Psychiatr 47 [suppl. 28]:79–84
Kamei H, Kameyama T, Nabeshima T (1996) (+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress through the activation of phenytoin-regulated sigma1 sites. Eur J Pharmacol 299:21–28
Kelly JP, Leonard BE (1994) The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology 33[8]: 1011–1016
Lane R, Baldwin D, Preskorn S (1995) The SSRIs—advantages, disadvantages and differences. J Psychopharmacol 9 [2 suppl S]: 163–178
Lightowler S, Kennett GA, Williamson IJR, Blackburn TP, Tulloch IF (1994) Anxiolytic-like effect of paroxetine in a rat social interaction test. Pharmacol Biochem Behav 49[2]: 281–285
Maj J, Rogóz Z, Skuza G (1982) Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activity. Eur J Pharmacol 81:287–292
Mogilnicka E, Szyrak A, Maj J (1987) Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. Eur J Pharmacol 138:413–416
Molewijk HE, van der Poel AM, Mos J, van der Heyden JAM, Olivier B (1995) Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs. Psychopharmacology 117:32–40
Nixon MK, Hascoet M, Bourin M, Colombel MC (1994) Additive effects of lithium and antidepressants in the forced swimming test:further evidence for involvement of the serotonergic system. Psychopharmacology 115:59–64
Olivier B (1992) Animal models in obsessive compulsive disorder. Int Clin Psychopharm 7[1]: 27–29
Olivier B, Mos J (1992) Rodent models of aggressive behavior and serotonergic drugs. Prog Neuro-Psychopharmacol Biol Psychiatry 16:847–870
Olivier B, Bosch L, van Hest A, van der Heyden J, Mos J, van der Poel G, Schipper J, Tulp M (1993) Preclinical evidence on the psychotropic profile of fluvoxamine. Pharmacopsychiatry 26:2–9
Perregaard J, Moltzen EK, Meier E and Sánchez C (1995) Novel sigma ligands with subnanomolar affinity and preference for the σ 2 binding site. Part 1. 3-(θ-aminoalkyl)-lH-indoles. J Med Chem 38:1998–2008
Plenge P, Mellerup ET, Laursen H (1991) Affinity modulation of [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets. Eur J Pharmacol 206:243–250
Porsolt RD, Bertin A, Jalfre M (1977) behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn 229:327–336
Porsolt RD, Bertin A, Blavet N, Deniel M, Jalfre M (1979) Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J Pharmacol 57:201–210
Rao TS, Cler JA, Mick SJ, Ragan DM, Lanthorn TH, Contreras, PC, Iyengar S, Wood PL (1990) Neurochemical characterization of dopaminergic effects of opipramol, a potent sigma receptor ligand, in vivo. Neuropharmacology 29:1191–1197
Sánchez C (1993) Effect of serotonergic drugs on footshock-induced ultrasonic vocalization in adult male rats. Behav Pharmacol 4: 269–277
Sánchez (1995) Serotonergic mechanisms involved in the exploratory behavior of mice in a fully automated two-compartment black and white test box. Pharmacol Toxicol 77:71–78
Sánchez (1996) 5-HT1A receptors play an important role in mediation of exploratory behavior of rats in a two-compartment black and white box. Behav Pharmacol (in press)
Sánchez C, Hyttel J (1994) Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors. Eur J Pharmacol 264:241–247
Sánchez C, Arnt J, Hyttel J, Moltzen EK (1993) The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice. Psychopharmacology 110:53–59
Sánchez C, Arnt J and Perregaard J (1994) Lu 28-179—a selective sigma ligand with potent anxiolytic effects. Soc Neurosci Abstr 20:164.16
Schmidt A, Lebel L, Koe BK, Seeger T, Heym J (1989) Sertraline potently displaces (+)-[3H]3-PPP binding to σ sites in rat brain. Eur J Pharmacol 165:335–336
Sheehan DV, Raj BA, Trehan RR, Knapp EL (1993) Serotonin in panic disorder and social phobia. Int Clin Psychopharmacol 8[2]: 63–77
Shirayama Y, Nishikawa T, Umino A, Takahashi K (1993) p-Chlorophenylalanine-reversible reduction of σ binding sites by chronic imipramine treatment in rat brain. Eur J Pharmacol 37:117–126
Weber E, Sonders M, Quarum M, McLean S, Pou S, Keana SFW (1986) l,2-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels σ-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci USA 83:8784–8788
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sánchez, C., Meier, E. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Psychopharmacology 129, 197–205 (1997). https://doi.org/10.1007/s002130050181
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002130050181